Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Community Dent Oral Epidemiol. 2009 Jul 14;37(5):427–437. doi: 10.1111/j.1600-0528.2009.00485.x

Table 3.

Metabolic characteristics of 112 HIV+ subjects

Metabolic Measures Median (Range) Normal Range N (%) in Normal Range
Lipids
  Cholesterol (mg/dL) 172 (93–261)   (80–200) 89 (80.9)
  HDL Cholesterol (mg/dL) 37 (18–97) >40 48 (43.6)
  LDL (mg/dL) 106 (27–181) <130 83 (76.9)
  VLDL (mg/dL) 22 (7–74)   0–40 95 (88.0)
  Triglycerides (mg/dL) 111 (34–652) <150 79 (71.8)
BMI (kg/m2) 26 (16–64)
  Underweight <18.5   2 (1.8)
  Normal 18.5–24.9 49 (44.5)
  Overweight 25–29.9 29 (26.4)
  Obese >30 30 (27.3)
Hs-CRP (mg/L) 1.8 (0.1–64.4)   <3.0 71 (65.1)
Insulin (µIU/ml) 4 (0–42)
Glucose (mg/dL) 91 (73–123) 70–110 105 (94.6)
HOMA-IR 0.88 (0–9.32) ≤2.6   99 (89.2)

Metabolic Measures: Body mass index (BMI), high-sensitivity C-reactive protein (hs-CRP), triglycerides (TRIG), high density lipoproteins (HDL), low density lipoproteins (LDL), very low density lipoproteins (VLDL), homeostasis model assessment-insulin resistance (HOMA-IR). Note: Normal range values for insulin are most appropriately interpreted within the context of HOMA-IR.